Navigation Links
Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
Date:9/5/2008

MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- A team of researchers at West Virginia University has shown that U.S. immigrants from India and Pakistan take on the habits of their adopted country, increasing their risks of prostate cancer among male immigrants and breast cancer among females.

"Breast cancer and prostate cancer develop due to many reasons, but environmental factors and lifestyle play a major role in these cancers," said Jame Abraham, M.D., medical director for WVU's Mary Babb Randolph Cancer Center and leader of the research team. "When men and women from India and Pakistan migrate to the United States, their disease profiles change, mirroring the American risk."

The study, to be published in the Sept. 15 issue of the journal Cancer, a peer-reviewed journal published by American Cancer Society, is the first epidemiological analysis of the Pakistani and Indian immigrant population. The authors looked at data from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute, examining almost 7,000 cases between 1988 and 2003.

In India, the No. 1 cancer among men is cancer of the mouth related to tobacco use, and the No. 1 cancer among women is cancer of the cervix, which could be caused by human papillomavirus (HPV), poor perinatal care and lack of screening and early detection. In the immigrant population, by contrast, the top cancer is prostate cancer for men and breast cancer for women.

The Pakistani and Indian immigrant population in the United States also experiences rising rates of lung and colon cancer, again mirroring U.S. patterns.

Immigrants have been shown to embrace the Western lifestyle of marrying later, having fewer children, getting less exercise and adopting a diet higher in fat, alcohol and meat, and lower in fiber.

"We need to educate the immigrant population about risk factors as well as preventive measures they can take to reduce their risk of prostate, breast cancer, lung cancer and colon cancer," Dr. Abraham said.

Immigrants from India and Pakistan make up about 1.5 percent of the U.S. population. They experience a better survival rate from cancer compared with the non-Hispanic white U.S. population.

Abraham's coauthors are Akm Hossain, M.D. and Aasim Sehbai, M.D., also with the WVU Cancer Center, and Rachel Abraham, M.D., of the WVU School of Medicine's Department of Community Medicine.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.


'/>"/>
SOURCE West Virginia University Health Sciences Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):